174 related articles for article (PubMed ID: 32062784)
1. The association of delay in curative intent treatment with survival among breast cancer patients: findings from the Women's Health Initiative.
Yung R; Ray RM; Roth J; Johnson L; Warnick G; Anderson GL; Kroenke CH; Chlebowski RT; Simon MS; Fung C; Pan K; Wang D; Barrington WE; Reding KW
Breast Cancer Res Treat; 2020 Apr; 180(3):747-757. PubMed ID: 32062784
[TBL] [Abstract][Full Text] [Related]
2. Impact of Breast Reconstruction on Time to Definitive Surgical Treatment, Adjuvant Therapy, and Breast Cancer Outcomes.
Jabo B; Lin AC; Aljehani MA; Ji L; Morgan JW; Selleck MJ; Kim HY; Lum SS
Ann Surg Oncol; 2018 Oct; 25(10):3096-3105. PubMed ID: 30014454
[TBL] [Abstract][Full Text] [Related]
3. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
Liu YR; Jiang YZ; Yu KD; Shao ZM
Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
[TBL] [Abstract][Full Text] [Related]
4. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
[TBL] [Abstract][Full Text] [Related]
5. The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study.
Liu Y; Tamimi RM; Collins LC; Schnitt SJ; Gilmore HL; Connolly JL; Colditz GA
Breast Cancer Res Treat; 2011 Aug; 129(1):175-84. PubMed ID: 21390493
[TBL] [Abstract][Full Text] [Related]
6. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
7. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
8. Impact of triple negative phenotype on breast cancer prognosis.
Kaplan HG; Malmgren JA
Breast J; 2008; 14(5):456-63. PubMed ID: 18657139
[TBL] [Abstract][Full Text] [Related]
9. Timeliness of Treatment Initiation in Newly Diagnosed Patients With Breast Cancer.
Dong J; Esham KS; Boehm L; Karim SA; Lin M; Mao D; Wang F; Fein D; Wang H; Studenmund C; Weidner RA; Noubary F; Freund KM; Erban JK; Parsons SK
Clin Breast Cancer; 2020 Feb; 20(1):e27-e35. PubMed ID: 31439436
[TBL] [Abstract][Full Text] [Related]
10. Delays in the presentation and diagnosis of women with breast cancer in Yogyakarta, Indonesia: A retrospective observational study.
Hutajulu SH; Prabandari YS; Bintoro BS; Wiranata JA; Widiastuti M; Suryani ND; Saptari RG; Taroeno-Hariadi KW; Kurnianda J; Purwanto I; Hardianti MS; Allsop MJ
PLoS One; 2022; 17(1):e0262468. PubMed ID: 35025941
[TBL] [Abstract][Full Text] [Related]
11. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.
Hershman DL; Wang X; McBride R; Jacobson JS; Grann VR; Neugut AI
Breast Cancer Res Treat; 2006 Oct; 99(3):313-21. PubMed ID: 16583264
[TBL] [Abstract][Full Text] [Related]
12. Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare.
Pathak R; Leslie M; Dondapati P; Davis R; Tanaka K; Jett E; Chervoneva I; Tanaka T
Breast Cancer; 2023 Jul; 30(4):627-636. PubMed ID: 37130988
[TBL] [Abstract][Full Text] [Related]
13. Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.
Sinha AK; Patel JR; Shen Y; Ueno NT; Giordano SH; Tripathy D; Lopez DS; Barcenas CH
PLoS One; 2017; 12(1):e0170081. PubMed ID: 28085940
[TBL] [Abstract][Full Text] [Related]
14. The impact of new systemic therapies on survival and time on hormonal treatment in hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer: A population-based study in British Columbia from 2003 to 2013.
Le D; Speers C; Thompson L; Gondara L; Nichol A; Lohrisch C
Cancer; 2020 Mar; 126(5):971-977. PubMed ID: 31750938
[TBL] [Abstract][Full Text] [Related]
15. Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period.
O'Sullivan CC; Irshad S; Wang Z; Tang Z; Umbricht C; Rosner GL; Christianson MS; Stearns V; Smith KL
Breast Cancer Res Treat; 2020 Apr; 180(3):695-706. PubMed ID: 32162192
[TBL] [Abstract][Full Text] [Related]
16. HR+/Her2- breast cancer in pre-menopausal women: The impact of younger age on clinical characteristics at diagnosis, disease management and survival.
De Camargo Cancela M; Comber H; Sharp L
Cancer Epidemiol; 2016 Dec; 45():162-168. PubMed ID: 27846443
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and outcomes following early-stage breast cancer.
Calip GS; Malone KE; Gralow JR; Stergachis A; Hubbard RA; Boudreau DM
Breast Cancer Res Treat; 2014 Nov; 148(2):363-77. PubMed ID: 25301086
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0-1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database.
Hu G; Hu G; Zhang C; Lin X; Shan M; Yu Y; Lu Y; Niu R; Ye H; Wang C; Xu C
BMC Cancer; 2020 Feb; 20(1):136. PubMed ID: 32085753
[TBL] [Abstract][Full Text] [Related]
19. Delayed initiation of adjuvant chemotherapy in older women with breast cancer.
Smith-Graziani D; Lei X; Giordano SH; Zhao H; Karuturi M; Chavez-MacGregor M
Cancer Med; 2020 Oct; 9(19):6961-6971. PubMed ID: 32767723
[TBL] [Abstract][Full Text] [Related]
20. Hormone receptor-negative breast cancer: undertreatment of patients over 80.
Weiss A; Noorbakhsh A; Tokin C; Chang D; Blair SL
Ann Surg Oncol; 2013 Oct; 20(10):3274-8. PubMed ID: 23838924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
